Heidi Overton, a physician and White House domestic policy adviser, was nominated in August following leadership turmoil at the FDA
The White House has withdrawn Dr Heidi Overton's nomination to lead the US Food and Drug Administration (FDA) amid concerns about Republican support ahead of a crucial Senate vote.
According to the Associated Press, the Trump administration announced the decision on Tuesday, just hours before Overton was scheduled to face a vote in the Senate health committee.
Overton, a physician and White House domestic policy adviser, was nominated in August following leadership turmoil at the FDA.
Her nomination faced questions from both Republicans and Democrats over her independence, particularly regarding vaccines and abortion policy.
Republican Senator Bill Cassidy had previously criticised her support for President Donald Trump's proposal to separate combination vaccines, including the measles, mumps and rubella shot.
However, Cassidy later suggested that disagreements over abortion, rather than vaccines, had contributed to the withdrawal.
“I believe she would have had the votes to pass out of committee and pass the full Senate,” Cassidy wrote on X.
He said anti-abortion Republicans had requested commitments on “life issues” that the administration declined to provide.
The withdrawal comes as the FDA reviews the safety of abortion medication mifepristone.
The agency is currently led by acting commissioner Kyle Diamantas following a period of leadership changes and significant staff departures.
It remains unclear whether Trump will nominate another candidate.